Diagnosis and treatment of subarachnoid hemorrhage
10.3760/cma.j.cn113694-20200729-00588
- VernacularTitle:蛛网膜下腔出血的诊断与治疗
- Author:
Chao QIN
1
;
Jingli LIU
Author Information
1. 广西医科大学第一附属医院神经内科，南宁 530021
- From:
Chinese Journal of Neurology
2020;53(10):814-818
- CountryChina
- Language:Chinese
-
Abstract:
Subarachnoid hemorrhage (SAH) is a common hemorrhagic cerebrovascular disease with high mortality and disability rate. Intracranial aneurysm is the major cause of SAH,severe and unbearable headache with meningeal irritation is the typical clinical manifestation of it,and the diagnosis is mainly confirmed by neuroimaging. The purpose of SAH treatment is to eradicate bleeding causes such as aneurysms and brain arteriovenous malformation (bAVM), eliminate brain edema and control intracranial pressure, prevent cerebral vasospasm and secondary cerebral ischemia, and deal with complications such as hydrocephalus actively. Two international multicenter randomized controlled trials, ISAT (International Subarachnoid Aneurysm Trial) and BRAT (Barrow Ruptured Aneurysm Trial), have provided new evidences for the treatment of aneurysmal subarachnoid hemorrhage. Multidisciplinary collaboration,consisting of neurosurgery, intervention and neurology departments, is an important guarantee for good clinical outcomes.
